Safety of citrate based hemofiltration in critically ill patients at high risk for bleeding: A comparison with nadroparin

International Journal of Artificial Organs

Volumn 29, Issue 6, 2006, Pages 559-563

  van der Voort, Peter H J ^a   Postma, S R ^a   Kingma, W P ^a   Boerma, E C ^a   van Roon, E N ^a  

^a MEDICAL CENTER LEEUWARDEN   (Netherlands)

Author keywords

Bleeding; Citrate; Hemofiltration

Indexed keywords

CELLS; INDIUM COMPOUNDS; MEDIAN FILTERS;

BLEEDINGS; BLOOD CELLS; CITRATE; COHORT STUDIES; CRITICALLY-ILL PATIENTS; FILTER RUN TIME; HEMOFILTRATION; HIGH VOLUMES; NONPARAMETRIC TESTS; PROSPECTIVES;

BLOOD;

CITRIC ACID; NADROPARIN;

ADULT; AGED; ANTICOAGULANT THERAPY; ARTICLE; BLEEDING; BLOOD CLOTTING DISORDER; BLOOD FILTRATION; CLINICAL TRIAL; COHORT ANALYSIS; COMPARATIVE STUDY; CONTINUOUS HEMOFILTRATION; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; CRITICAL ILLNESS; CRITICALLY ILL PATIENT; DISEASE SEVERITY; DRUG EFFICACY; DRUG SAFETY; ERYTHROCYTE TRANSFUSION; GASTROINTESTINAL HEMORRHAGE; HIGH RISK PATIENT; HUMAN; INCIDENCE; MAJOR CLINICAL STUDY; MULTIPLE ORGAN FAILURE; OBSERVATIONAL METHOD; RISK ASSESSMENT; TREATMENT INDICATION; TREATMENT OUTCOME; UPPER GASTROINTESTINAL BLEEDING;

EID: 33746531773     PISSN: 03913988     EISSN: None     Source Type: Journal    
DOI: 10.1177/039139880602900603     Document Type: Article

References (16)

1. Mehta RL, Letteri JM. Current status of renal replacement therapy for acute renal failure. A Survey of US nephrologists. The National Kidney Foundation Council on Dialysis. Am J Nephrol 1999; 19:377-82.
2. Bellomo R, Ronco C. Continuous renal replacement therapy in the intensive care unit. Intensive Care Med 1999; 25:781-9.
3. Ronco C, Bellomo R. Continuous renal replacement therapy: Evolution in technology and current nomenclature. Kidney Int Suppl 1998; 66:S160-4.
4. Van de Wetering J, Westendorp RG, van der Hoeven JG, Stolk B, Feuth JD, Chang PC. Heparin use in continuous renal replacement procedures: The struggle between filter clotting and patient hemorrhage. J Am Soc Nephrol 1996: 7: 145-50.
5. Tan HK, Baldwin I, Bellomo R. Continuous veno-venous hemofiltration without anticoagulation in high-risk patients. Intensive Care Med 2000; 26:1652-7.
6. Tolwani AJ, Campbell RC, Schenk MB, Allon M, Warnock DG. Simplified citrate anticoagulation for continuous renal replacement therapy. Kidney Int 2001; 60:370-4.
7. Mehta RL, McDonald BR, Aguilar MM, Ward DM. Regional citrate anticoagulation for continuous arteriovenous hemodialysis in critically ill patients. Kidney Int 1990; 38: 976-81.
8. Hofmann RM, Maloney C, Ward DM, Becker BN. A novel method for regional citrate anticoagulation in continuous venovenous hemofiltration (CVVHF). Ren Fail 2002; 24: 325-35.
9. Kutsogiannis DJ, Gibney RT, Stollery D, Gao J. Regional citrate vesus systemic heparin anticoagulation for continuous renal replacement in critically ill patients. Kidney Int 2005; 67: 2361-7.
10. Monchi M, Berghmans D, Ledoux D, Canivet JL, Dubois B, Damas P. Citrate vs. heparin for anticoagulation in continuous venovenous hemofiltration: A prospective randomized study. Intensive Care Med 2004; 30: 260-5.
11. Palsson R, Niles JL. Regional citrate anticoagulation in continuous venovous hemofiltration in critically ill patients with a high risk of bleeding. Kidney Int 1999; 55:1991-7.
12. Nice Data Dictionary: Www.stichting-nice.nl (last accessed October 13, 2005).
13. Thoenen M, Schmid ER, Binswanger U, Schuepbach R, Aerne D, Schmidlin D. Regional citrate anticoagulation using a citrate-based substitution solution for continuous venovenous hemofiltration in cardiac surgery patients. Wien Kiln Wochenschr 2002; 114:108-14.
14. Van der Voort PH, Gerritsen RT, Kuiper MA, Egbers PHM, Kingma WP, Boerma EC. Filter run time in CVVH: Pre- versus post-dilution and nadroparin versus regional heparin- protamine anticoagulation. Blood Purif 2005; 23:175-80.
15. De Pont AC, Oudemans-van Straaten, HM, Roozendaal KF, Zandstra DF. Nadroparin versus dalteparin anticoagulation in high-volume, continuous venovenous haemofiltration: A double-blind, randomized, crossover study. Crit Care Med 2000; 28:421-5.
16. Reeves JH, Cumming AR, Gallagher L, O'Brien JL, Santamaria JD. A controlled trial of low-molecular-weight heparin (dalteparin) versus unfractionated heparin as anticoagulant during continuous venovenous hemodialysis with filtration. Crit Care Med 1999; 27: 2224-8.